Latest / The Dales Report | Trade to Black
Zappy Zapolin’s 2024 Update On The Psychedelic Renaissance
Zappy Zapolin, an award-winning filmmaker and psychedelic entrepreneur joins us with his take on the progress of the second wave of the psychedelic renaissance and the upside for psychedelic stocks. Host Shadd Dales asks about the ongoing FDA priority review for Lykos Therapeutics MDMA-assisted therapy (formerly MAPS PBC) and the chances of it passing.
In addition, we talk about highlights of 2024 including the capital raising of psychedelic companies like Beckley Psytech, Cybin, Mind Med, Reunion Neuroscience, and Lykos Therapeutics and the industry progress in clinical trials. Zappy is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.